IpiNovyx Bio Closes on $10 Million Seed Financing Round to Advance Proprietary Platform
The following was taken from Trialsitenews--continue reading here "New York-based IpiNovyx Bio announced the closing of a $10 million...
Search
- Oct 6, 2021
IpiNovyx Bio closes $10 million seed financing round
The below is an excerpt taken from EndPoints News. Read more here or continue reading below. "With a focus on autoimmune and inflammatory...
- Oct 6, 2021
Eli Lilly-backed IpiNovyx Bio emerges with $10M for 2023 clinical entry
We are excited to announce our launch! The following was taken from Fierce Biotech--read it here or continue below! "Eli Lilly is among...